Synopsys Inc (SNPS) Shares Surge 4.1% -- What GF Score of 95 Tells Investors
On May 22, 2026, Synopsys Inc (SNPS) shares rose 4.1% to a current price of $524.74. This price is situated between a 52-week high of $651.73 and a low of $376.
SNPS - Synopsys, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$543.57
DETAILS
HIGH:
$600.00
LOW:
$455.00
MEDIAN:
$550.00
CONSENSUS:
$543.57
UPSIDE:
3.59%
Stock News
Synopsys to Report Q2 Earnings: What's in Store for the Stock?
SNPS heads into Q2 earnings results with AI-driven chip demand and Synopsys.ai adoption expected to support revenue growth.
Synopsys (SNPS) Outpaces Stock Market Gains: What You Should Know
Synopsys (SNPS) closed the most recent trading day at $503.98, moving +1.01% from the previous trading session.
Ahead of Synopsys (SNPS) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Synopsys (SNPS) for the quarter ended April 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Synopsys Should Be Priced Far Higher Given The AI Megatrend
Synopsys is a critical AI value chain bottleneck, yet its stock has underperformed despite robust fundamentals and market position. I rate SNPS a 'strong buy' due to its essential EDA tools, virtual duopoly status, and undervaluation versus peers on both P/E and EV/Revenue bases. My DCF and comps analysis yield a fair value of $586.83, implying 17.7% upside, supported by 15% annualized revenue growth and 42% operating margins.
Wall Street Bulls Look Optimistic About Synopsys (SNPS): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Arm Holdings Has Doubled in 2026. Is It Outperforming Other Chip-IP Stocks Like Synopsys, Cadence, and Qualcomm?
Shares of Arm Holdings (NASDAQ:ARM | ARM Price Prediction) are trading higher by 4% in midday action Tuesday, extending a year that has put the chip-IP designer in a class of its own among semiconductor design names.
Prediction: Synopsys Could Hit $600+ in 12 Months and Here's Why
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) has whipsawed investors over the past year, from an August 2025 peak near $617.91 to a November low of $389.83, before settling at $498.43.
PRGS or SNPS: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Computer - Software sector might want to consider either Progress Software (PRGS) or Synopsys (SNPS). But which of these two stocks offers value investors a better bang for their buck right now?
Buy, Sell or Hold Synopsis Below $500?
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) below $500 looks priced for an AI story the business does not fully support.
Nvidia's Hidden Portfolio Just Doubled Down on CoreWeave Stock
Artificial intelligence is no longer just about who builds the fastest chips.
Synopsys (SNPS) Registers a Bigger Fall Than the Market: Important Facts to Note
Synopsys (SNPS) concluded the recent trading session at $501.52, signifying a -1.67% move from its prior day's close.
Synopsys Price Prediction: The AI Play With Big Upside This Year
Synopsys (NASDAQ:SNPS | SNPS Price Prediction) has staged one of the more dramatic comebacks in semiconductor software, climbing 21.78% in the past month after a brutal stretch through late 2025.
Synopsys: Ansys Integration Has Reinforced The Quality Growth Story
Synopsys (SNPS) has positioned itself as a dominant EDA software provider, further strengthened by the Ansys acquisition and structural AI tailwinds. The Ansys deal expands SNPS's TAM by 63% to $31B, enabling integrated chip-to-system simulation and reinforcing its competitive moat. Despite a forward P/E of ~35.8, SNPS's compounding EPS growth, high margins, and visible catalysts justify a long-term Quality Growth thesis.
Is SNPS Overvalued? DCF Says Worth $354
On May 08, 2026, we delve into the DCF analysis for Synopsys Inc (SNPS), a company that has shown notable price performance recently. Over the past month, SNPS
Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Synopsys (SNPS) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Synopsys (SNPS) closed at $497.5, marking a +1.73% move from the previous day.
Wall Street Analysts Think Synopsys (SNPS) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
PRGS vs. SNPS: Which Stock Is the Better Value Option?
Investors interested in Computer - Software stocks are likely familiar with Progress Software (PRGS) and Synopsys (SNPS). But which of these two stocks offers value investors a better bang for their buck right now?
Price Targets
Goldman Sachs on Synopsys (SNPS): 'We expect the stock to be range bound'
$600.00
(was $449.17)
James Schneider
·
Goldman Sachs
Synopsys downgraded to Hold from Buy at HSBC
$455.00
(was $444.62)
HSBC
Synopsys downgraded to Neutral from Overweight at Piper Sandler
$520.00
(was $533.42)
Piper Sandler
Synopsys price target raised to $550 from $510 at Morgan Stanley
$550.00
(was $462.05)
Morgan Stanley
Synopsys price target raised to $580 from $550 at Needham
$580.00
(was $470.90)
Needham
Synopsys price target lowered to $602 from $630 at Piper Sandler
$602.00
(was $475.73)
Piper Sandler
Synopsys price target raised to $500 from $445 at Wells Fargo
$500.00
(was $475.73)
Joe Quatrochi
·
Wells Fargo
Synopsys price target raised to $600 from $575 at KeyBanc
$600.00
(was $475.73)
Jason Celino
·
KeyBanc
Synopsys price target lowered to $445 from $550 at Wells Fargo
$445.00
(was $404.63)
Joe Quatrochi
·
Wells Fargo
Synopsys initiated with an Underperform at BNP Paribas Exane
$425.00
(was $488.78)
BNP Paribas
Synopsys price target lowered to $550 from $660 at Needham
$550.00
(was $387.78)
Charles Shi
·
Needham
Synopsys price target lowered to $630 from $660 at Piper Sandler
$630.00
(was $387.78)
Piper Sandler
Synopsys price target lowered to $550 from $630 at Wells Fargo
$550.00
(was $387.78)
Wells Fargo
Synopsys price target lowered to $590 from $660 at KeyBanc
$590.00
(was $387.78)
KeyBanc
Synopsys downgraded to Neutral from Outperform at Baird
$535.00
(was $387.78)
Robert W. Baird
Synopsys (SNPS) PT Raised to $660 at KeyBanc
$660.00
(was $592.01)
Jason Celino
·
KeyBanc
Synopsys price target lowered to $540 from $575 at KeyBanc
$540.00
(was $466.26)
Jason Celino
·
KeyBanc
Synopsys price target raised to $575 from $555 at KeyBanc
$575.00
(was $515.61)
Jason Celino
·
KeyBanc
Synopsys price target lowered to $550 from $620 at Stifel
$550.00
(was $443.97)
Stifel Nicolaus
Needham Reiterates Buy Rating on Synopsys (SNPS)
$640.00
(was $505.59)
Charles Shi
·
Needham